ID   NCH612
AC   CVCL_X913
DR   cancercelllines; CVCL_X913
DR   CLS; 300121
DR   Wikidata; Q54907711
RX   PubMed=29563135;
CC   Group: Cancer stem cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Unspecified (CLS=300121).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11,13
ST   D18S51: 13
ST   D21S11: 28,31
ST   D3S1358: 14,18
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 11,14
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 05-10-23; Version: 13
//
RX   PubMed=29563135; DOI=10.1158/1078-0432.CCR-17-1839;
RA   Dettling S., Stamova S., Warta R., Schnolzer M., Rapp C.,
RA   Rathinasamy A., Reuss D., Pocha K., Roesch S., Jungk C., Warnken U.,
RA   Eckstein V., Grabe N., Schramm C., Weigand M.A., von Deimling A.,
RA   Unterberg A., Beckhove P., Herold-Mende C.;
RT   "Identification of CRKII, CFL1, CNTN1, NME2, and TKT as novel and
RT   frequent T-cell targets in human IDH-mutant glioma.";
RL   Clin. Cancer Res. 24:2951-2962(2018).
//